Balyasny Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Balyasny Asset Management’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,205	Closed	-$93K	–	2201
2020 Q4	$93K	Buy	+10,205	New	+$78.9K	﹤0.01%	1252
2018 Q1	–	Sell	-280,000	Closed	-$1.84M	–	2436
2017 Q4	$1.84M	Buy	280,000 +269,500	+2,567%	+$1.65M	0.01%	1156
2017 Q3	$58K	Buy	+10,500	New	+$70.9K	﹤0.01%	1813
2017 Q2	–	Sell	-116,200	Closed	-$1.05M	–	1846
2017 Q1	$1.05M	Buy	+116,200	New	+$1.21M	﹤0.01%	1079
2016 Q1	–	Sell	-11,860	Closed	-$129K	–	1600
2015 Q4	$129K	Buy	+11,860	New	+$107K	﹤0.01%	1143
2015 Q3	–	Sell	-11,430	Closed	-$104K	–	1454
2015 Q2	$104K	Buy	+11,430	New	+$86.6K	﹤0.01%	1071

Other funds holding NPTN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Balyasny Asset Management's NPTN Position: Q1 2021 in Review

Balyasny Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q1 2021, closing a stake of 10,205 shares — an estimated $93K sold.

Balyasny Asset Management first reported a position in NPTN in Q2 2015 and held it in 6 quarters. The position peaked at $1.84M in Q4 2017. 147 funds tracked by Wall St. Rank hold NPTN as of Q1 2021.

Balyasny Asset Management reported no remaining NEOPHOTONICS CORP position as of Q1 2021 after selling out during the quarter.
Balyasny Asset Management sold 10,205 NEOPHOTONICS CORP shares in Q1 2021, an estimated $93K.
Balyasny Asset Management first reported a position in NEOPHOTONICS CORP in Q2 2015 and held it in 6 quarters.
Balyasny Asset Management's NEOPHOTONICS CORP position peaked at $1.84M in Q4 2017.
147 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2021.

Based on Balyasny Asset Management's 13F filing for Q1 2021, filed 17 May 2021.